Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Jianliang Gao

Biographic Data

ID7958823
NAMEJianliang Gao
GIVEN NAMESJianliang
FAMILY NAMEGao
SIGNATUREGAO J
AFFILIATIONSAnhui Medical University
ORCID0000-0002-9363-9908
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
AUTHOR COUNT4
EDITOR COUNT0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2024
H-INDEX0
  • Effects of aripiprazole on prolactin levels and differences in effectiveness in patients with schizophrenia

    Open Access•Qian Li, Yun‐Ai Su et al.•ARTICLE•Frontiers in Psychiatry•2024

    In this real-world study, for patients with acute schizophrenia, aripiprazole was effective in lowering the proportion of patients with abnormal prolactin levels, while it had no significant effect on patients with normal baseline prolactin. After adjusting for factors such as sex, age, prior antipsychotic drugs use history and disease severity, effectiveness and safety of aripiprazole in patients with normal baseline prolactin was significantly …

  • Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients

    Open Access•Junwei Yan, Yuanyuan Chen et al.•ARTICLE•Frontiers in Psychiatry•2022

    Our study revealed a complex interactive network correlation among the cardiovascular risk factors, biological immunity profiles, and psychotic symptoms in first-episode patients. Abnormal inflammatory factors and CVD risk factors had high sensitivity and specificity for predicting SCZ symptoms. Generally, our study provided novel information on the immune-related mechanisms involved in early CVD risk in patients with psychotic disorders

  • Childhood maltreatment increases the suicidal risk in Chinese schizophrenia patients

    Open Access•Peng Cheng, Peijun Ju et al.•ARTICLE•Frontiers in Psychiatry•2022

    Relapsed group of patients had significantly more severe childhood trauma, recent psychosocial stress, suicidal risk and proneness to suicidal behavior. BMI and emotional neglect are unique predictors for different dimensions of suicide

  • Potential Role of Pain Catastrophic Thinking in Comorbidity Patients of Depression and Chronic Pain

    Open Access•Yuanyuan Chen, Peijun Ju et al.•ARTICLE•Frontiers in Psychiatry•2022

    Our results suggested that the pain-related catastrophic thinking and anxiety were more severe in the comorbidity group than in MDD-only group and healthy group. Pain-related catastrophizing thoughts and anxiety may have potentially effects on the comorbidity of depression and chronic pain

No prominent works on this page.

  • Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients

    Open Access•Junwei Yan, Yuanyuan Chen et al.•ARTICLE•Frontiers in Psychiatry•2022

    Our study revealed a complex interactive network correlation among the cardiovascular risk factors, biological immunity profiles, and psychotic symptoms in first-episode patients. Abnormal inflammatory factors and CVD risk factors had high sensitivity and specificity for predicting SCZ symptoms. Generally, our study provided novel information on the immune-related mechanisms involved in early CVD risk in patients with psychotic disorders

  • Childhood maltreatment increases the suicidal risk in Chinese schizophrenia patients

    Open Access•Peng Cheng, Peijun Ju et al.•ARTICLE•Frontiers in Psychiatry•2022

    Relapsed group of patients had significantly more severe childhood trauma, recent psychosocial stress, suicidal risk and proneness to suicidal behavior. BMI and emotional neglect are unique predictors for different dimensions of suicide

  • Potential Role of Pain Catastrophic Thinking in Comorbidity Patients of Depression and Chronic Pain

    Open Access•Yuanyuan Chen, Peijun Ju et al.•ARTICLE•Frontiers in Psychiatry•2022

    Our results suggested that the pain-related catastrophic thinking and anxiety were more severe in the comorbidity group than in MDD-only group and healthy group. Pain-related catastrophizing thoughts and anxiety may have potentially effects on the comorbidity of depression and chronic pain

  • Effects of aripiprazole on prolactin levels and differences in effectiveness in patients with schizophrenia

    Open Access•Qian Li, Yun‐Ai Su et al.•ARTICLE•Frontiers in Psychiatry•2024

    In this real-world study, for patients with acute schizophrenia, aripiprazole was effective in lowering the proportion of patients with abnormal prolactin levels, while it had no significant effect on patients with normal baseline prolactin. After adjusting for factors such as sex, age, prior antipsychotic drugs use history and disease severity, effectiveness and safety of aripiprazole in patients with normal baseline prolactin was significantly …

Medicine (4 works) · Psychiatry (4 works) · Psychology (3 works) · Schizophrenia (object-oriented programming (3 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Internal Medicine (2 works) · Schizophrenia research and treatment (2 works) · Antipsychotic (1 work) · Anxiety (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae